Beta Blockers May Also Help Lung Cancer Patients Live Longer

Beta Blockers May Also Help Lung Cancer Patients Live Longer.
New enquiry suggests that beta blockers, medications that are old to curb blood strength and heart rhythms, may also help lung cancer patients fare longer. The researchers found that patients with non-small-cell lung cancer being treated with shedding lived 22 percent longer if they were also taking these drugs 4 dollar generic cvs. "These findings were the first, to our knowledge, demonstrating a survival help associated with the use of beta blockers and diffusion analysis for lung cancer," said lead researcher Dr Daniel Gomez, an deputy professor in the department of radiation oncology at the University of Texas MD Anderson Cancer Center in Houston.

So "The results mean that there may be another mechanism, in great measure unexplored, that could potentially slim the rates of tumor spread in patients with this very warlike disease". The report was published Jan 9, 2013 in the Annals of Oncology. For the study, Gomez's side compared the outcomes of more than 700 patients undergoing emission treatment for lung cancer.

The investigators found that the 155 patients taking beta blockers for quintessence problems lived an average of almost two years, compared with an normal of 18,6 months for patients not taking these drugs. The findings held even after adjusting for other factors such as age, division of the disease, whether or not chemotherapy was given at the same time, spirit of chronic obstructive pulmonary disorder and aspirin use, the researchers noted. Beta blockers also improved survival without the affliction spreading to other parts of the body and survival without the disease recurring.